AXOFT, INC.
Biotechnology · Cambridge, MA
BiotechnologySEC Form D
AXOFT, INC. filed a Form D with the U.S. Securities and Exchange Commission on May 7, 2026, reporting $34,245,380 raised toward a $34,245,399 offering.
Incorporated in Delaware and based in Cambridge, MA, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that AXOFT, INC. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Paul Le FlochExecutive Officer · Director
- Chia An LeeDirector
- Benjamin PlessDirector
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$10.0MRaised